212 related articles for article (PubMed ID: 12198247)
1. Angiotensin II subtype 2 receptor activation inhibits insulin-induced phosphoinositide 3-kinase and Akt and induces apoptosis in PC12W cells.
Cui TX; Nakagami H; Nahmias C; Shiuchi T; Takeda-Matsubara Y; Li JM; Wu L; Iwai M; Horiuchi M
Mol Endocrinol; 2002 Sep; 16(9):2113-23. PubMed ID: 12198247
[TBL] [Abstract][Full Text] [Related]
2. Muscarinic-receptor-mediated inhibition of insulin-like growth factor-1 receptor-stimulated phosphoinositide 3-kinase signalling in 1321N1 astrocytoma cells.
Batty IH; Fleming IN; Downes CP
Biochem J; 2004 May; 379(Pt 3):641-51. PubMed ID: 14769130
[TBL] [Abstract][Full Text] [Related]
3. Functional trans-inactivation of insulin receptor kinase by growth-inhibitory angiotensin II AT2 receptor.
Elbaz N; Bedecs K; Masson M; Sutren M; Strosberg AD; Nahmias C
Mol Endocrinol; 2000 Jun; 14(6):795-804. PubMed ID: 10847582
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II blocks nicotine-mediated neuroprotection against beta-amyloid (1-42) via activation of the tyrosine phosphatase SHP-1.
Shaw S; Bencherif M; Marrero MB
J Neurosci; 2003 Dec; 23(35):11224-8. PubMed ID: 14657181
[TBL] [Abstract][Full Text] [Related]
5. Fatty acid-induced insulin resistance: decreased muscle PI3K activation but unchanged Akt phosphorylation.
Kruszynska YT; Worrall DS; Ofrecio J; Frias JP; Macaraeg G; Olefsky JM
J Clin Endocrinol Metab; 2002 Jan; 87(1):226-34. PubMed ID: 11788651
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II impairs the insulin signaling pathway promoting production of nitric oxide by inducing phosphorylation of insulin receptor substrate-1 on Ser312 and Ser616 in human umbilical vein endothelial cells.
Andreozzi F; Laratta E; Sciacqua A; Perticone F; Sesti G
Circ Res; 2004 May; 94(9):1211-8. PubMed ID: 15044323
[TBL] [Abstract][Full Text] [Related]
7. Interferon-dependent activation of the serine kinase PI 3'-kinase requires engagement of the IRS pathway but not the Stat pathway.
Uddin S; Majchrzak B; Wang PC; Modi S; Khan MK; Fish EN; Platanias LC
Biochem Biophys Res Commun; 2000 Apr; 270(1):158-62. PubMed ID: 10733921
[TBL] [Abstract][Full Text] [Related]
8. The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase/Akt activation by growth factors.
Wu CJ; O'Rourke DM; Feng GS; Johnson GR; Wang Q; Greene MI
Oncogene; 2001 Sep; 20(42):6018-25. PubMed ID: 11593409
[TBL] [Abstract][Full Text] [Related]
9. Galphaq/11 signaling induces apoptosis through two pathways involving reduction of Akt phosphorylation and activation of RhoA in HeLa cells.
Ueda H; Morishita R; Narumiya S; Kato K; Asano T
Exp Cell Res; 2004 Aug; 298(1):207-17. PubMed ID: 15242775
[TBL] [Abstract][Full Text] [Related]
10. In vivo activation of insulin receptor tyrosine kinase by melatonin in the rat hypothalamus.
Anhê GF; Caperuto LC; Pereira-Da-Silva M; Souza LC; Hirata AE; Velloso LA; Cipolla-Neto J; Carvalho CR
J Neurochem; 2004 Aug; 90(3):559-66. PubMed ID: 15255933
[TBL] [Abstract][Full Text] [Related]
11. Pivotal role of tyrosine phosphatase SHP-1 in AT2 receptor-mediated apoptosis in rat fetal vascular smooth muscle cell.
Cui T; Nakagami H; Iwai M; Takeda Y; Shiuchi T; Daviet L; Nahmias C; Horiuchi M
Cardiovasc Res; 2001 Mar; 49(4):863-71. PubMed ID: 11230986
[TBL] [Abstract][Full Text] [Related]
12. A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1.
Ozes ON; Akca H; Mayo LD; Gustin JA; Maehama T; Dixon JE; Donner DB
Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4640-5. PubMed ID: 11287630
[TBL] [Abstract][Full Text] [Related]
13. Glucosamine infusion in rats rapidly impairs insulin stimulation of phosphoinositide 3-kinase but does not alter activation of Akt/protein kinase B in skeletal muscle.
Kim YB; Zhu JS; Zierath JR; Shen HQ; Baron AD; Kahn BB
Diabetes; 1999 Feb; 48(2):310-20. PubMed ID: 10334307
[TBL] [Abstract][Full Text] [Related]
14. nitric oxide triggers the phosphatidylinositol 3-kinase/Akt survival pathway in insulin-producing RINm5F cells by arousing Src to activate insulin receptor substrate-1.
Tejedo JR; Cahuana GM; Ramírez R; Esbert M; Jiménez J; Sobrino F; Bedoya FJ
Endocrinology; 2004 May; 145(5):2319-27. PubMed ID: 14764634
[TBL] [Abstract][Full Text] [Related]
15. The neuroprotective effect of 2-(3-pyridyl)-1-azabicyclo[3.2.2]nonane (TC-1698), a novel alpha7 ligand, is prevented through angiotensin II activation of a tyrosine phosphatase.
Marrero MB; Papke RL; Bhatti BS; Shaw S; Bencherif M
J Pharmacol Exp Ther; 2004 Apr; 309(1):16-27. PubMed ID: 14722323
[TBL] [Abstract][Full Text] [Related]
16. Suppressor of cytokine signaling-3 Provides a novel interface in the cross-talk between angiotensin II and insulin signaling systems.
Calegari VC; Alves M; Picardi PK; Inoue RY; Franchini KG; Saad MJ; Velloso LA
Endocrinology; 2005 Feb; 146(2):579-88. PubMed ID: 15514089
[TBL] [Abstract][Full Text] [Related]
17. The cross-talk between angiotensin and insulin differentially affects phosphatidylinositol 3-kinase- and mitogen-activated protein kinase-mediated signaling in rat heart: implications for insulin resistance.
Carvalheira JB; Calegari VC; Zecchin HG; Nadruz W; Guimarães RB; Ribeiro EB; Franchini KG; Velloso LA; Saad MJ
Endocrinology; 2003 Dec; 144(12):5604-14. PubMed ID: 12960006
[TBL] [Abstract][Full Text] [Related]
18. Reciprocal feedback regulation of insulin receptor and insulin receptor substrate tyrosine phosphorylation by phosphoinositide 3-kinase in primary adipocytes.
Hers I; Bell CJ; Poole AW; Jiang D; Denton RM; Schaefer E; Tavaré JM
Biochem J; 2002 Dec; 368(Pt 3):875-84. PubMed ID: 12220227
[TBL] [Abstract][Full Text] [Related]
19. Interaction of insulin receptor substrate-1 (IRS-1) with phosphatidylinositol 3-kinase: effect of substitution of serine for alanine in potential IRS-1 serine phosphorylation sites.
Delahaye L; Mothe-Satney I; Myers MG; White MF; Van Obberghen E
Endocrinology; 1998 Dec; 139(12):4911-9. PubMed ID: 9832428
[TBL] [Abstract][Full Text] [Related]
20. Insulin substrates 1 and 2 are corequired for activation of atypical protein kinase C and Cbl-dependent phosphatidylinositol 3-kinase during insulin action in immortalized brown adipocytes.
Miura A; Sajan MP; Standaert ML; Bandyopadhyay G; Kahn CR; Farese RV
Biochemistry; 2004 Dec; 43(49):15503-9. PubMed ID: 15581362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
